Head of Quality Systems - (Norwood, MA)

Who We Are ImmunoGen is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology. ImmunoGen's lead product applicant, mirvetuximab soravtansine, is being advanced to a Phase three trial for FRa-positive platinum-resistant ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease. ImmunoGen's ADC technology is used in Roche's marketed product, Kadcyla, in 3 other clinical-stage ImmunoGen product applicants, and in programs in development by partners Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda. More info about ImmunoGen can be found at www.immunogen.com. The Opportunity Under the direction of the Vice President of Regulatory and Quality, this position will provide leadership and direction to the Quality Details System and Documentation Management teams.